合成生物学周报：天津大学合成生物与生物制造学院正式揭牌，凯赛生物出资成立新公司

Investment Rating - The industry investment rating is "Overweight" [1] Core Insights - The report highlights the active research in life sciences and the global wave of biotechnology revolution, which is providing new solutions to major challenges such as health, climate change, resource security, and food security. The National Development and Reform Commission has issued the "14th Five-Year Plan for Biological Economy Development," indicating a trillion-yuan market potential in the biological economy [3][4]. Summary by Sections 1. Industry Market Dynamics - The synthetic biology sector has seen a decline of 8.90% in the recent week, ranking 32nd among various sectors [15]. - The synthetic biology index, which includes 58 companies, has underperformed compared to the Shanghai Composite Index and the ChiNext Index by 10.82% and 12.17%, respectively [4]. 2. Company Business Progress - Tianjin University has established the first synthetic biology and biomanufacturing college in China, aiming to cultivate innovative talents in response to the biotechnology revolution [7]. - Kasei Biotech and South Korea's 3P.COM have jointly established Hefei Hydrogen He New Materials Co., focusing on bio-based materials technology [8]. - The report mentions several projects and collaborations, including a biomass-based project by Luzhou Tianhua and Shanxi Coal Chemical Institute, and a partnership between Bio Island Laboratory and Wanhua Chemical [22][23]. 3. Industry Financing Tracking - The report notes an acceleration in financing for synthetic biology companies, with nearly a hundred companies completing new financing rounds since the beginning of 2025. For instance, Suzhou Yulu Qianxing Biotechnology completed several million yuan in Series A financing [27]. - Atlas Data Storage has raised $150 million in seed funding, setting a new record in the field, focusing on DNA storage technology [29].